[1] Loi's research has advanced understanding into breast cancer, developing and implementing an immune system biomarker.
This biomarker is now part of routine pathology reporting across many countries and also is included in the World Health Organization Classification of Tumours (the WHO Blue Book on Breast Tumors).
[citation needed] Loi has, from 2018 to 2020, ranked in the top 1% of global researchers,[2] according to the Web of Science, with more than 240 peer-reviewed publications.
Her research uses genomic medicine to translate interesting scientific findings to improve outcomes for breast cancer patients.
The Association states "she is a pioneer in designing and executing clinical trials using immunotherapy agents for the treatment of breast cancer.